Sanofi (SNY)
44.61
+0.24
(+0.54%)
USD |
NASDAQ |
Sep 02, 14:06
Sanofi Net Income (TTM) : 4.656B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.656B |
| December 31, 2025 | 5.585B |
| June 30, 2025 | 6.791B |
| December 31, 2024 | 5.790B |
| June 30, 2024 | 4.369B |
| December 31, 2023 | 5.876B |
| June 30, 2023 | 9.051B |
| December 31, 2022 | 8.852B |
| June 30, 2022 | 7.578B |
| December 31, 2021 | 7.397B |
| June 30, 2021 | 6.954B |
| December 31, 2020 | 13.84B |
| June 30, 2020 | 12.32B |
| December 31, 2019 | 3.281B |
| June 30, 2019 | 4.184B |
| December 31, 2018 | 5.201B |
| June 30, 2018 | 4.008B |
| December 31, 2017 | 4.359B |
| June 30, 2017 | 5.296B |
| December 31, 2016 | 4.958B |
| June 30, 2016 | 4.699B |
| December 31, 2015 | 5.004B |
| June 30, 2015 | 5.864B |
| December 31, 2014 | 5.962B |
| June 30, 2014 | 5.793B |
| Date | Value |
|---|---|
| December 31, 2013 | 5.152B |
| June 30, 2013 | 4.531B |
| December 31, 2012 | 6.510B |
| June 30, 2012 | 8.902B |
| December 31, 2011 | 8.239B |
| June 30, 2011 | 5.912B |
| December 31, 2010 | 7.059B |
| June 30, 2010 | 8.304B |
| December 31, 2009 | 7.666B |
| June 30, 2009 | 6.258B |
| December 31, 2008 | 6.386B |
| June 30, 2008 | 7.904B |
| December 31, 2007 | 7.797B |
| June 30, 2007 | 6.183B |
| December 31, 2006 | 5.530B |
| June 30, 2006 | 4.812B |
| December 31, 2005 | 3.214B |
| June 30, 2005 | 2.871B |
| December 31, 2004 | 2.791B |
| June 30, 2004 | 2.820B |
| December 31, 2003 | 2.355B |
| June 30, 2003 | 1.970B |
| December 31, 2002 | 1.745B |
| June 30, 2002 | 1.635B |
| December 31, 2001 | 1.417B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| AstraZeneca PLC | 10.40B |
| GSK Plc | 7.078B |
| Johnson & Johnson | 21.04B |
| Eli Lilly & Co. | 26.71B |
| Merck & Co., Inc. | 3.169B |